• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

需氧革兰氏阴性血培养分离株对恶喹酸、诺氟沙星、环丙沙星、依诺沙星、培氟沙星、氧氟沙星和氧恶喹酸的体外敏感性

In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.

作者信息

Van der Auwera P

出版信息

Infection. 1986 May-Jun;14(3):142-4. doi: 10.1007/BF01643481.

DOI:10.1007/BF01643481
PMID:2942489
Abstract

100 gram-negative strains isolated from blood cultures were selected for the evaluation of the in vitro activity of oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin. Ciprofloxacin showed the highest intrinsic activity. Oxo-enoxacin, the major metabolite of enoxacin, was 10-15-fold less active than enoxacin. Against Enterobacteriaceae and Vibrionaceae, all fluorinated quinolones except norfloxacin were equally effective, while against non-fermenters, ciprofloxacin and ofloxacin demonstrated greater activity than the others. Resistance to oxolinic acid had a detrimental effect on susceptibility to the new fluorinated quinolones.

摘要

从血培养物中分离出100株革兰氏阴性菌株,用于评估恶喹酸、诺氟沙星、环丙沙星、依诺沙星、培氟沙星、氧氟沙星和氧代依诺沙星的体外活性。环丙沙星显示出最高的内在活性。依诺沙星的主要代谢产物氧代依诺沙星的活性比依诺沙星低10至15倍。在针对肠杆菌科和弧菌科方面,除诺氟沙星外的所有氟喹诺酮类药物效果相同,而在针对非发酵菌方面,环丙沙星和氧氟沙星显示出比其他药物更强的活性。对恶喹酸的耐药性对新型氟喹诺酮类药物的敏感性有不利影响。

相似文献

1
In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.需氧革兰氏阴性血培养分离株对恶喹酸、诺氟沙星、环丙沙星、依诺沙星、培氟沙星、氧氟沙星和氧恶喹酸的体外敏感性
Infection. 1986 May-Jun;14(3):142-4. doi: 10.1007/BF01643481.
2
In-vitro activity of newer quinolones against aerobic bacteria.新型喹诺酮类药物对需氧菌的体外活性
J Antimicrob Chemother. 1986 Apr;17 Suppl B:29-39. doi: 10.1093/jac/17.suppl_b.29.
3
[In vitro activity of new quinolones against Mycoplasma pathogenic to humans].新型喹诺酮类药物对人致病性支原体的体外活性
Pathol Biol (Paris). 1988 May;36(5):496-9.
4
Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.培氟沙星、氧氟沙星、依诺沙星和环丙沙星对256株临床分离株的体外活性比较
Acta Pathol Microbiol Immunol Scand B. 1987 Apr;95(2):141-6. doi: 10.1111/j.1699-0463.1987.tb03102.x.
5
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.八种新型喹诺酮类药物与萘啶酸的体外活性比较
J Antimicrob Chemother. 1986 Nov;18 Suppl D:1-20. doi: 10.1093/jac/18.supplement_d.1.
6
Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.环丙沙星、依诺沙星、诺氟沙星、氧氟沙星和培氟沙星对脆弱拟杆菌和艰难梭菌的体外活性比较
Scand J Infect Dis. 1986;18(2):149-51. doi: 10.3109/00365548609032321.
7
Comparative in vitro studies with 4-quinolone antimicrobials.4-喹诺酮类抗菌药物的体外比较研究。
Drugs Exp Clin Res. 1985;11(5):317-29.
8
Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.依诺沙星、环丙沙星、阿米氟沙星、诺氟沙星和氧氟沙星对177株细菌分离株的抗菌活性比较
J Antimicrob Chemother. 1986 May;17(5):623-8. doi: 10.1093/jac/17.5.623.
9
Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.七种喹诺酮类药物对100株艰难梭菌临床分离株的体外活性比较
Antimicrob Agents Chemother. 1986 Feb;29(2):374-5. doi: 10.1128/AAC.29.2.374.
10
Frequency and expression of mutational resistance to the 4-quinolone antibacterials.对4-喹诺酮类抗菌药物的突变耐药性的频率和表达
Scand J Infect Dis Suppl. 1986;49:115-23.

引用本文的文献

1
High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia.高剂量阿糖胞苷治疗急性髓性白血病后发生链球菌败血症的高风险。
Klin Wochenschr. 1987 Aug 17;65(16):773-80. doi: 10.1007/BF01743253.
2
Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia.环丙沙星和诺氟沙星用于严重粒细胞减少患者的选择性肠道去污。
Infection. 1988 Mar-Apr;16(2):98-104. doi: 10.1007/BF01644312.
3
Concentrations of ofloxacin in serum and cerebrospinal fluid of patients without meningitis receiving the drug intravenously and orally.

本文引用的文献

1
In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives.环丙沙星与其他新型含氟哌嗪基取代喹啉衍生物的体外活性比较。
Antimicrob Agents Chemother. 1984 Apr;25(4):518-21. doi: 10.1128/AAC.25.4.518.
2
Pharmacokinetics and tissue penetration of ciprofloxacin.环丙沙星的药代动力学及组织穿透性
Antimicrob Agents Chemother. 1983 Nov;24(5):784-6. doi: 10.1128/AAC.24.5.784.
3
The pharmacokinetics and tissue penetration of ofloxacin.氧氟沙星的药代动力学和组织穿透性。 (注:原文中多了一个of,正确表述应该是The pharmacokinetics and tissue penetration of ofloxacin )
静脉和口服给药的无脑膜炎患者血清及脑脊液中的氧氟沙星浓度。
Antimicrob Agents Chemother. 1989 Oct;33(10):1686-90. doi: 10.1128/AAC.33.10.1686.
4
Pharmacokinetics of enoxacin and its oxometabolite following intravenous administration to patients with different degrees of renal impairment.依诺沙星及其氧化代谢产物在不同程度肾功能损害患者静脉给药后的药代动力学。
Antimicrob Agents Chemother. 1990 Aug;34(8):1491-7. doi: 10.1128/AAC.34.8.1491.
J Antimicrob Chemother. 1984 Dec;14(6):647-52. doi: 10.1093/jac/14.6.647.
4
Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis.培氟沙星在脑膜炎患者脑脊液中的穿透情况。
Antimicrob Agents Chemother. 1984 Sep;26(3):289-91. doi: 10.1128/AAC.26.3.289.
5
Enoxacin: worldwide in-vitro activity against 22451 clinical isolates.
J Antimicrob Chemother. 1984 Sep;14 Suppl C:47-55. doi: 10.1093/jac/14.suppl_c.47.
6
Pharmacokinetics and tissue penetration of enoxacin.依诺沙星的药代动力学和组织穿透性。
Antimicrob Agents Chemother. 1984 Jul;26(1):17-9. doi: 10.1128/AAC.26.1.17.
7
Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.环丙沙星在正常志愿者中的多剂量药代动力学及安全性
Antimicrob Agents Chemother. 1984 Nov;26(5):741-4. doi: 10.1128/AAC.26.5.741.
8
Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.五种喹啉衍生物与用于口腔治疗的其他五种抗菌剂的体外活性比较
Eur J Clin Microbiol. 1984 Aug;3(4):333-8. doi: 10.1007/BF01977489.
9
The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.环丙沙星与诺氟沙星和萘啶酸的体外活性比较。
J Antimicrob Chemother. 1984 Apr;13(4):325-31. doi: 10.1093/jac/13.4.325.
10
The pharmacokinetics and tissue penetration of norfloxacin.诺氟沙星的药代动力学及组织穿透性。
J Antimicrob Chemother. 1984 Jan;13(1):87-92. doi: 10.1093/jac/13.1.87.